Skip to main content

MDxHealth Signs Distribution Deal for Prostate Cancer Test in Hong Kong, Macao

NEW YORK (GenomeWeb) – MDxHealth announced today that it has signed on AceCGT Life Sciences Limited as the exclusive distributor of its SelectMDx for Prostate Cancer test in Hong Kong and Macao.

Under the terms of their agreement, AceCGT will send patient samples for analysis to MDxHealth's ISO-certified clinical diagnostic lab in Nijmegen, The Netherlands for analysis. Additional terms were not disclosed.

"With their highly qualified and experienced team of laboratory scientists, clinical researchers, and a dedicated commercial team, AceCGT Group is an ideal partner to help us raise awareness and expand access to SelectMDx throughout Hong Kong and Macao," MDxHealth CEO Jan Groen said in a statement.

The deal with AceCGT marks the latest in a series of distribution agreements MDxHealth has recently signed for SelectMDx including ones covering Central and South America, Poland, and Israel.